Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 28, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2025

Conditions
Advanced CancerAdvanced Solid TumorLymphoma, HodgkinCentral Nervous System TumorSarcomaGerm Cell TumorPediatric Cancer
Interventions
DIETARY_SUPPLEMENT

Ocoxin Oral solution

Patients will receive one vial of Ocoxin® orally daily, preferably at the same time each day. The duration of treatment will depend on the chemotherapy schedule the patient will receive. Treatment with Ocoxin® will be from the start of oncospecific therapy until two weeks after the end of therapy.

Trial Locations (1)

504

Hospital Escuela, Tegucigalpa (Honduras), Tegucigalpa

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT06363201 - Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | Biotech Hunter | Biotech Hunter